Vimarsana
Biggest News Aggregation in the World

Page 6 - Mobile Opera News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mobile Opera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mobile Opera Today - Breaking & Trending Today

EMS agency practices affect out-of-hospital cardiac arrest survival rates - Vimarsana News

EMS agency practices affect out-of-hospital cardiac arrest survival rates

Differences in emergency medical service agency resuscitation practices may partly account for widely varying out-of-hospital cardiac arrest survival rates, researchers reported in Circulation: Cardiovascular Quality and Outcomes.“Our work highlights how important it is for emergency medical service agencies to review their resuscitation performance, and all related practices, to evaluate

Source: healio.com
Statin use for CVD may lower risk for COVID-19 hospitalizations, deaths - Vimarsana News

Statin use for CVD may lower risk for COVID-19 hospitalizations, deaths

Statin use for primary prevention of CVD was associated with lower risk for COVID-19 hospitalizations and in-hospital deaths, according to findings from a cohort study published in the Journal of the American Heart Association.“Statins are now known to be beneficial in primary prevention, decreasing all-cause mortality, cardiovascular disease, coronary heart disease and stroke,” Kim

Source: healio.com
Top news of June: Clarifying aspirin recommendations; vocal features predict AF; and more - Vimarsana News

Top news of June: Clarifying aspirin recommendations; vocal features predict AF; and more

Healio and Cardiology Today have compiled the most-read cardiology news of June 2022.Readers were most interested in improving the messaging surrounding aspirin; the midterm CV safety of men’s hormone therapy; promotion of hands-only CPR to increase use and improve cardiac arrest outcomes; and more.

Source: healio.com
Continuous subcutaneous foslevodopa/foscarbidopa infusion shows promise in phase 3 study - Vimarsana News

Continuous subcutaneous foslevodopa/foscarbidopa infusion shows promise in phase 3 study

Continuous subcutaneous infusion of foslevodopa/foscarbidopa was safe and improved motor complications in patients with advanced Parkinson’s disease, according to data presented at the European Academy of Neurology Congress 2022. “ABBV-951 (foslevodopa/foscarbidopa) is a solution of levodopa and carbidopa prodrugs for continuous subcutaneous infusion being investigated for the

Source: healio.com
Impaired exercise ventilatory efficiency contributes to dyspnea, exercise limitation in COPD - Vimarsana News

Impaired exercise ventilatory efficiency contributes to dyspnea, exercise limitation in COPD

Impaired exercise ventilatory efficiency above the upper limit of normal was associated with a greater dyspnea burden and low peak VO2 among never smokers and smokers with or without COPD, researchers reported.“Activity-related dyspnea and exercise limitation ... are common, even in mild COPD, and are associated with poor health status and increased mortality. The traditional focus of

Source: healio.com